Intro


Hi and welcome! My name is Jennie Dickerson, and I will be using this site to incorporate the curriculum of MGMT 7160 into the business practices of Medtronic. Join me in this final semester on the journey towards the culmination of the Masters of Business Administration program at the University of Memphis.


Monday, September 29, 2014

Medtronic's VRIO Assessment

Value: Do Medtronic’s resources and capabilities enable the firm to respond to environmental threats or opportunities?
Medtronic has a variety of successful product lines based all over the world. It has exceptional resources in the financial, physical, human and organizational categories. Financially, it has continually grown its resources. In Medtronic’s most recent annual report, it shows that the stock price has increased continually since 2009. Physically, it has acquired numerous smaller firms, acquiring all of their research and product lines. In addition, Medtronic has several regional offices all over the world. Its human resources create the innovation and technology that has made them so successful. Medtronic’s website says it has an “innovative culture where passionate people are encouraged and flourish. If your job search ends at Medtronic, you'll find yourself collaborating with some of the brightest minds in the healthcare industry.” From an organization standpoint, Medtronic is doing well not only coming up with the technology but capitalizing on it. Its growing stock success can attest to that.

Rarity: How many competing firms already possess particular valuable resources and capabilities?
According to MorningStar, there are 25 other firms in the same industry as Medtronic. The top several firms are serious competitors, some with interests in similar markets as Medtronic. Medtronic is not the only firm in the business, so it does not have rarity as a competitive advantage. However, even in the top competitors, there is only one who is directly in Medtronic’s range. Abbott Laboratories and Medtronic have similar numbers across the board. Is it the only firm in the business? No. Does it have more resources and capabilities than the vast majority of competitors? Absolutely.

Imitability: Do firms without a resource or capability face a cost disadvantage in obtaining it compared to firms that already possess it?
Firms that do not already possess Medtronic’s research and development and trade secrets of their products would have to spend lots of money to create a rival product. Last year alone, Medtronic’s research and development budget was $1.5 billion. Medtronic has bought up smaller companies and high performing firms around the world. If another firm wanted to buy their way into the market, they would have to beat Medtronic to the deal. The medical device industry, in general, requires high capital investment. New firms face a high barrier to entry and difficulty imitating Medtronic’s products.

Organization: Is a firm organized to exploit the full competitive potential of its resources and capabilities?
In addition to developing great technology, Medtronic has a lot of other organizational advantages. First, Medtronic develops its leaders. The company values innovative thinking and encourages leadership development for the ultimate benefit of the company and the development of its technology. Medtronic also has its businesses organized into three main departments that have subdepartments—these groups work together, making the best use of knowledge and resources. Their locations are divided by the best places for manufacturing, research, and other departments to be. Most recently, Medtronic has attempted to avoid millions of dollars in corporate taxation by moving its headquarters to a newly acquired company in Ireland. The company is using all of its resources, expertise and capabilities to fully exploit its profitability.



Monday, September 22, 2014

Evaluating Environmental Opportunities and Neutralizing Threats

Evaluating Opportunities:

Medtronic is the largest medical technology company, operating in 140 countries. It has seven different business divisions, all located in different places. For Medtronic to have become so successful, it has had to make strategic business decisions and adapt to the market, as well as neutralize threats in order to keep competition low. Based on the products and services Medtronic offers, the company is classified as a member of emerging industries in a global market.

Emerging Industries: Medtronic employs a technological leadership strategy in emerging industries because it is always introducing new, innovative products into the market. With a company based on ever-improving technology, Medtronic and the medical technology industry can be classified as emerging, although it has been around for more than 60 years. In addition to consistently adding new technology, Medtronic is adding markets, and successfully. Last year alone, 13% of the company’s total revenue came from emerging markets, where the demand for these technologically advanced products is growing rapidly.

Global Market Opportunities: Medtronic utilizes a global strategy. Rather than changing strategies for other countries, Medtronic can focus on the same technology and advancements because the product it sells does not change based on cultural preferences. Medical technology is the same for people all over the world. In the FY14 annual report, CEO Omar Ishrak discusses the acquisition of Covidien and the resulting growth of their global strategy. This acquisition means existing research and development and know-how and increases shareholder’s revenues.

Neutralizing Threats:

Threat of Entry: Medtronic is in a position in the industry where it has erected barriers to entry. With its large workforce and global strategy, it has exploited economies of scale by acquiring and merging with other companies to become the largest medical technology company. Its products are highly differentiated and its research and development teams are constantly releasing new technology. In addition to these barriers, it has also been able to reduce costs independent of scale by moving its business office to Ireland to take advantage of a tax shelter. This one act has saved Medtronic millions of dollars each year.


Threat of Rivalry: Medtronic also competes with firms in the industry on dimensions other than price. Its products are differentiated with advanced technology beyond that of its competitors. In addition, the company’s products and services are diversified, thriving with seven divisions that are all focused on different types of medical technology. From Cardiac Rhythm and Heart Failure Management to Diabetes Care, Medtronic has a division for multiple, unrelated yet common health problem. Regardless of a competitor’s success in one market, Medtronic still dominates the industry with types and performance of several technologies.

Sources:

Medtronic FY 14 Annual Report:

Medtronic Investor Page:

Sunday, September 21, 2014

Medtronic and Porter’s 5 Forces Model

The Threat of Entry:
Medtronic is one of the world’s leading companies that provides medical technology devices. Its products are technologically advanced and require extensive research and development. The threat of entry for a new company in this industry is high. Medtronic has the advantage of economies of scale because its strategy is acquisitions and mergers. Recently, Medtronic has acquired several smaller firms and released several new products, including an “implantable cardiac monitor, or ICM…The device is roughly one-third the size of a triple A battery -- about 80% smaller than comparable ICMs.” This product launched in February and has achieved 4% growth in the company division in its first quarter. This is one example of the advantage of product differentiation that would be a low threat of entry. Medtronic can use its brand recognition and reputation for high quality products to ensure trust with customers for new products, like this heart monitor.

Threat of Rivalry:
Medtronic’s main competitors are Abbott Laboratories, Stryker Corp, St Jude Medical Inc and market share leader, Johnson & Johnson. These companies are acquiring companies worldwide, making the market smaller. Industry growth is strong and product differentiation is high. Based on the attributes of the threat of rivalry, the threat of rivalry for Medtronic is moderate.

The Threat of Substitutes: 

 The threat of substitutes is moderate for Medtronic. The company’s devices are expensive and not ubiquitous throughout the health care industry. While hospitals all over the world use Medtronic’s technology, some are forced to make the best diagnosis with what they have. These doctors use older methods to treat patients for a less accurate and less expensive visit.

Threat of Suppliers:

The medical technology business is dominated by a few firms that sell highly differentiated products. Suppliers are not very threated by substitutes. Based on this assessment, the threat of suppliers is moderate to high.

Threat of Buyers:

In the industry of medical technology, the threat of buyers is low. With the aging Boomer population and a culture that does not value proactive, healthy living, the need for medical devices for a variety of ailments grows every day. Products and services provided by Medtronic affect and improve the quality of life for people. For anyone who can afford such care, this expense would be priceless to the patient. The number of buyers is high and the products are differentiated. Buyers are earning significant products by way of life and mobility improvement.

Sources:



Sunday, September 7, 2014

Competitive Advantage and Firm Performance

Medtronic’s website claims that it is “the world’s largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and extending life.” In 2013 alone, more than 10 million people received medical therapies. Medtronic’s products care for “cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions.” Medtronic is in the right business, as Forbes has claimed that health technology companies are one of the fastest growing fields. With increased technology, an aging Baby Boomer’s population, and more of a concern about remaining healthy longer, Medtronic’s products are highly sought after.

Medtronic’s competitive advantage is that it is one of the few companies in the world that is so diversified in the business of health technology. Its divisions create products and treatments for a wide array of ailments. In addition to their traditional projects, Medtronic has announced new research trials for devices helping with Parkinson’s disease, patients with heart failure and a device for those with vision loss. They are in the business of improving quality of life, something everyone experiencing pain is in the market for. For most who can afford it, the economic benefit of reduced pain or health issues, the economic value far outweighs the cost. Because the firm is health technology based and competition on its scale is limited, the competitive advantage is sustained.

As far as firm performance, the data speaks Medtronic’s praise. Not only is Medtronic 173 on the 2014 Fortune 500 list, but it is doing well in the NYSE, averaging between $52.00-$64.00 a share. Recently, its value neared its 52 week high. In the midst of several acquisitions and mergers, as well as its decision to seek a tax shelter in Ireland, Medtronic has made the business news frequently, and its increase in stock price shows an increased value in light of these decisions. The tax shelter example is clear way that Medtronic has cut down on economic costs.

Sources:
http://www.medtronic.com/about-us/company-profile/medical-technology.htm?loc=MDTHomeRefresh_B_InPage_SubNav_Company_Line2_3